Lung Cancer News and Research

Latest Lung Cancer News and Research

AMTR soon after failure of AEDs may reduce risk of seizures in epilepsy patients

Patients with epilepsy who underwent brain surgery soon after failing to respond to drug treatment, but who also continued to receive drug therapy, had a lower risk of seizures during the 2nd year of follow-up compared to patients who received drug treatment alone, according to a study in the March 7 issue of JAMA.

7 Mar 2012

Smoking and lung cancer notice turns fifty but 20% Britons still smoke: Report

According to health experts, it has been five decades after doctors issued their first warning about the dangers of cigarettes. Still more than 20 percent of Britons still smoke - and unless they quit, half of them will die from the habit. Smoking has killed more than six million people in Britain since 1962, when the Royal College of Physicians (RCP) published a landmark report about the health risks of tobacco.

7 Mar 2012

Colon cancer screening guidelines released

According to a new guidance statement from the American College of Physicians all adults should get screened for colon cancer once they get older to reduce their risk of dying from the nation's number two cancer killer.

7 Mar 2012

A&G, Mayo Medical sign license agreement for new progranulin blood test for FTD

Mayo Clinic today announced that Mayo Medical Laboratories has signed an agreement with A&G Pharmaceutical, Inc. and will receive a non-exclusive license to certain patent rights and proprietary antibody reagents for the detection and measurement of progranulin in blood.

7 Mar 2012

CU Cancer Center aims to make progress against squamous cell lung cancer

Recent advances in targeted cancer treatments greatly bolster the prognosis for many types of lung cancer, but according to a University of Colorado Cancer Center investigator, "practically nothing has improved in squamous cell lung cancer in the last decades."

7 Mar 2012

Special computer algorithms can help doctors to make rapid diagnoses of known diseases

Just like urine and blood, breath contains traces of the products of metabolism. Such products can also be signs of infection, inflammation or cancer. For their analysis, computational bioinformatics researchers at the Cluster of Excellence "Multimodal Computing and Interaction" at Saarland University developed special computer algorithms that can help doctors to make diagnoses quickly and reliably.

5 Mar 2012

Diesel exhaust fumes linked to lung cancer among miners

It has been known that diesel exhaust may be a probable carcinogen. But the 20-year study from the National Cancer Institute took a closer look in the Diesel Exhaust in Miners Study, which followed 12,315 miners working in eight underground nonmetal mining facilities. Data were collected on the miners' health and exposure to various elements and chemicals from the time when the mine company first introduced diesel-powered equipment (between 1947 and 1967) until the end of the study in 1997. They breathed varying levels of exhaust from diesel-powered equipment, levels higher than the general population encounters.

4 Mar 2012

Heavy DE exposure may increase risk of dying from lung cancer

Heavy diesel exhaust (DE) exposure in humans may increase the risk of dying from lung cancer, according to two papers released March 2nd by the Journal of the National Cancer Institute.

3 Mar 2012

Early surgical intervention stops seizures and improves quality of life

While the thought of any type of surgery can be disconcerting, the thought of brain surgery can be downright frightening. But for people with a particular form of epilepsy, surgical intervention can literally be life-restoring.

3 Mar 2012

Older women face increased risk of late stage breast cancer diagnosis

Older women with breast cancer face a higher risk of being diagnosed with the disease at a late stage, while the risk of an advanced stage diagnosis of lung cancer decreases with age, a new study shows today.

3 Mar 2012

1.3 million cancer deaths in 2012 in the EU: Report

New research released this Wednesday shows that almost 1.3 million people will die of cancer in the European Union this year, but death rates from the disease are on a steady decline.

1 Mar 2012

New robotic surgical system can treat early-stage lung cancer

In a Canadian first, thoracic surgeons at Toronto General Hospital, University Health Network used a robotic surgical system to treat early-stage lung cancer by removing the cancer, along with a lobe of the lung. The use of this system improves outcomes after surgery and will expand the numbers of patients who can benefit from this type of minimally invasive surgical treatment.

1 Mar 2012

Springer adds 6 new quarterly clinical review journals to medicine portfolio

Springer is adding six new quarterly clinical review journals to its existing medicine portfolio in March 2012. These new journals will expand the publisher's medical specialty coverage, focusing on dermatology, geriatrics/gerontology, nutrition, obesity, obstetrics/gynecology and respiratory care.

29 Feb 2012

Cancer survival rates on the rise in Northern Ireland

Despite the rising incidence of cancer in Northern Ireland, the number of people surviving the disease in the country is increasing significantly year on year.

29 Feb 2012

EpiCept fourth quarter revenue decreases to $0.2 million

EpiCept Corporation today announced operating and financial results for the fourth quarter and full year ended December 31, 2011, and provided an update on the Company's key business initiatives.

29 Feb 2012

Nurses play a key role in alleviating cancer patients' concerns

Often faced with overwhelming anxiety, patients newly diagnosed with lung cancer can find themselves in distress, and new research recommends nurses play a key role in alleviating concerns, leading to a better quality of life for patients.

29 Feb 2012

XL888 inhibitor can prevent vemurafenib resistance in melanoma patients

Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues in California have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma.

29 Feb 2012

Aurora-A protein blocks proper functioning of tumor-suppressor p73

A protein abundantly found in treatment-resistant cancers holds an important tumor-suppressor out of the cell nucleus, where it would normally detect DNA damage and force defective cells to kill themselves, a team of scientists reports in the current Cancer Cell.

28 Feb 2012

Biodesix, Kadmon enter Phase 3 non-small cell lung cancer study collaboration

Biodesix Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, today announced a collaboration with Kadmon Corporation, LLC, to explore the utility of Biodesix' VeriStrat® test in a Phase 3 non-small cell lung cancer (NSCLC) study of Kadmon's KD019, a reversible tyrosine kinase inhibitor (TKI) targeting EGFR, HER2, VEGFR2 & 3, and SRC.

27 Feb 2012

Targeting versican protein may help stop breast cancer metastasis

Oncologists have known that in order for cancer cells to spread, they must transform themselves so they can detach from a tumor and spread to a distant organ. Now, scientists at Weill Cornell Medical College have revealed critical steps in what happens next -- how these cells reverse the process, morphing back into classical cancer that can now grow into a new tumor.

23 Feb 2012